Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer

P Taverna1, L Liu, H S Hwang

  • 1Division of Hematology-Oncology, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, OH 44106-4937, USA.

Mutation Research
|October 5, 2001
PubMed

Insights

Methoxyamine (MX) enhances temozolomide (TMZ) chemotherapy by increasing DNA damage in cancer cells. This potentiation, particularly in MMR-deficient cells, leads to DNA fragmentation and apoptosis, overcoming resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • DNA Repair Mechanisms

Background:

  • DNA mismatch repair (MMR) deficient cancer cells exhibit resistance to temozolomide (TMZ).
  • Methoxyamine (MX), a base excision repair (BER) inhibitor, can sensitize these cells to TMZ.
  • Understanding BER's role in response to TMZ-induced DNA damage is crucial for optimizing cancer therapy.

Purpose of the Study:

  • To investigate the effect of MX on TMZ-induced DNA single-strand breaks (SSB) and double-strand breaks (DSB).
  • To characterize the role of MMR status in the formation of TMZ-induced DNA damage in colon cancer cells.
  • To elucidate the mechanism by which MX potentiates TMZ cytotoxicity, especially in MMR-deficient cells.

Main Methods:

  • Evaluation of TMZ-induced SSB using alkaline elution in SW480 (MMR proficient) and HCT116 (MMR deficient) colon cancer cells.
  • Assessment of TMZ-induced DSB using pulsed-field gel electrophoresis in both cell lines.
  • Analysis of DNA repair protein levels and enzymatic activity in response to TMZ and MX treatment.

Main Results:

  • MX significantly increased TMZ-induced SSB in both MMR proficient and deficient cells.
  • TMZ-induced DSB were dependent on MMR status and time; MMR-deficient cells showed significant DSB only with TMZ plus MX.
  • MX and TMZ combination inhibited DNA cleavage activity, suggesting persistence of apurinic/apyrimidinic sites, leading to DS-DNA fragmentation and apoptosis in MMR-deficient cells.

Conclusions:

  • Methoxyamine potentiates temozolomide cytotoxicity by increasing DNA single-strand breaks and promoting double-strand break formation, particularly in MMR-deficient colon cancer cells.
  • The mechanism involves the persistence of unrepaired apurinic/apyrimidinic sites, leading to significant DNA fragmentation and subsequent apoptotic signaling, thereby overcoming TMZ resistance.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...